Who Owns GRCE?

Grace Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$2.12

-0.04 (-1.85%)

Market Cap

$55.5M

Shares Outstanding

15,474,000

Institutional Holders

17

Total Inst. Value

$9.2M

% of Float Held

QoQ Holder Change

+8

Institutional data as of Q1 2025

New Positions

4

Closed Positions

2

Increased

5

Decreased

7

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AIGH Capital Management LLC$3.0M1,322,379
2Nantahala Capital Management, LLCNew$2.7M1,178,203
3BANK OF AMERICA CORP /DE/$1.1M494,698
4ADAR1 Capital Management, LLC$783K343,512
5Stonepine Capital Management, LLCNew$666K294,550
6VANGUARD GROUP INC$582K255,400
7Palumbo Wealth Management LLCNew$105K46,007
8RENAISSANCE TECHNOLOGIES LLC$96K42,181
9CITADEL ADVISORS LLC$88K38,403
10Tower Research Capital LLC (TRC)$8K3,429

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold GRCE?

As of Q1 2025, 17 institutional investors report holding GRCE (Grace Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most GRCE?

The largest institutional holder of GRCE is AIGH Capital Management LLC with $3.0M in shares.

Are institutions buying or selling GRCE?

This quarter, 4 institutions opened new positions in GRCE and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.